These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 940439)
1. Delta9-tetrahydrocannabinol: depression of ventilatory regulation; other respiratory and cardiovascular effects. Moss IR; Friedman E Life Sci; 1976 Jul; 19(1):99-104. PubMed ID: 940439 [No Abstract] [Full Text] [Related]
2. Cardiopulmonary effects of cannabidiol in anesthetized mongrel dogs. Bright TP; Farber MO; Brown DJ; Lewis SC; Forney RB Toxicol Appl Pharmacol; 1975 Mar; 31(3):520-6. PubMed ID: 238308 [No Abstract] [Full Text] [Related]
3. Effect of delta9-tetrahydrocannabinol on experimental hypertension in rats. Varma DR; Goldbaum D J Pharm Pharmacol; 1975 Oct; 27(10):790-1. PubMed ID: 241799 [No Abstract] [Full Text] [Related]
4. Single-dose effect of marihuana smoke. Bronchial dynamics and respiratory-center sensitivity in normal subjects. Vachon L; FitzGerald MX; Solliday NH; Gould IA; Gaensler EA N Engl J Med; 1973 May; 288(19):985-9. PubMed ID: 4696254 [No Abstract] [Full Text] [Related]
5. Antibacterial activity of delta9-tetrahydrocannabinol and cannabidiol. Van Klingeren B; Ten Ham M Antonie Van Leeuwenhoek; 1976; 42(1-2):9-12. PubMed ID: 1085130 [TBL] [Abstract][Full Text] [Related]
6. Hemodynamic and myocardial effects of (-)-delta9-trans-tetrahydrocannabinol in anesthetized dogs. Cavero I; Buckley JP; Jandhyala BS Eur J Pharmacol; 1973 Nov; 24(2):243-51. PubMed ID: 4765747 [No Abstract] [Full Text] [Related]
7. Acute pulmonary physiologic effects of smoked marijuana and oral (Delta)9 -tetrahydrocannabinol in healthy young men. Tashkin DP; Shapiro BJ; Frank IM N Engl J Med; 1973 Aug; 289(7):336-41. PubMed ID: 4718513 [No Abstract] [Full Text] [Related]
8. Certain observations on interrelationships between respiratory and cardiovascular effects of (-)- 9 -trans-tetrahydrocannabinol. Cavero I; Kubena RK; Dziak J; Buckley JP; Jandhyala BS Res Commun Chem Pathol Pharmacol; 1972 May; 3(3):483-92. PubMed ID: 5034510 [No Abstract] [Full Text] [Related]
9. Combination of delta9-tetrahydrocannabinol with oxymorphone or pentobarbital: Effects on ventilatory control and cardiovascular dynamics. Johnstone RE; Lief PL; Kulp RA; Smith TC Anesthesiology; 1975 Jun; 42(6):674-84. PubMed ID: 48348 [TBL] [Abstract][Full Text] [Related]
10. A comparison of the pharmacological activity in man of intravenously administered delta9-tetrahydrocannabinol, cannabinol, and cannabidiol. Perez-Reyes M; Timmons MC; Davis KH; Wall EM Experientia; 1973 Nov; 29(11):1368-9. PubMed ID: 4761242 [No Abstract] [Full Text] [Related]
11. A randomised controlled trial of vaporised Δ Solowij N; Broyd S; Greenwood LM; van Hell H; Martelozzo D; Rueb K; Todd J; Liu Z; Galettis P; Martin J; Murray R; Jones A; Michie PT; Croft R Eur Arch Psychiatry Clin Neurosci; 2019 Feb; 269(1):17-35. PubMed ID: 30661105 [TBL] [Abstract][Full Text] [Related]
13. Cannabidiol and its pharmacokinetic interaction with delta1-tetrahydrocannabinol. Levy S; McCallum NK Experientia; 1975 Nov; 31(11):1268-9. PubMed ID: 1204768 [TBL] [Abstract][Full Text] [Related]
14. Marihuana-like activity of new synthetic tetrahydrocannabinols. Martin BR; Dewey WL; Harris LS; Beckner J Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625 [TBL] [Abstract][Full Text] [Related]